QQ客服 官方微博 反馈留言

	Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study
	Huo, Y.; Jing, Z. C.; Zeng, X. F.; Liu, J. M.; Yu, Z. X.; Zhang, G. C.; Li, Y.; Wang, Y.; Ji, Q. S.; Zhu, P.
	2016
卷号	16期号:1页码:201
关键词	Ambrisentan Chinese Exercise capacity Pulmonary arterial hypertension
ISSN号	1471-2261
DOI	10.1186/s12872-016-0361-9
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6384489
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Huo, Y.,Jing, Z. C.,Zeng, X. F.,et al. Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study[J],2016,16(1):201.
APA	Huo, Y..,Jing, Z. C..,Zeng, X. F..,Liu, J. M..,Yu, Z. X..,...&Li, J..(2016).Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study.,16(1),201.
MLA	Huo, Y.,et al."Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study".16.1(2016):201.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。